Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-10 5:02 pm Sale | 2021-12-20 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX, L.P. | 19,185,720 14.700% | -2,589,653 (-11.89%) | Filing History |
| 2021-07-12 5:02 pm Sale | 2021-06-22 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX, L.P. | 21,775,373 16.700% | -4,915,244 (-18.42%) | Filing History |
| 2021-04-22 7:22 pm Sale | 2021-04-13 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX, L.P. | 2,946,891 10.000% | -135,744 (-4.40%) | Filing History |
| 2021-04-14 5:23 pm Sale | 2021-03-30 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX, L.P. | 26,690,617 20.900% | -1,976,046 (-6.89%) | Filing History |
| 2021-02-02 4:13 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX, L.P. | 8,243,039 13.500% | 8,243,039 (New Position) | Filing History |
| 2021-01-19 1:25 pm Sale | 2021-01-08 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX, L.P. | 3,082,635 11.500% | -280,237 (-8.33%) | Filing History |